Outcomes in stroke patients with malignancy vary with cancer type, stroke treatment

In-hospital outcomes for acute ischemic stroke patients with solid organ malignancy varied depending on the type of cancer and use of stroke interventions, according to a study published in Neurology.
“Solid organ malignancy is associated with an increased incidence of acute ischemic stroke (AIS),” Aayushi Garg, MD, of the department of neurology at the University of Iowa Hospitals and Clinics, and colleagues wrote. “There is further evidence to support that patients with malignancy also have a higher risk of early complications, disability, recurrent thromboembolic events

In-hospital outcomes for acute ischemic stroke patients with solid organ malignancy varied depending on the type of cancer and use of stroke interventions, according to a study published in Neurology.
“Solid organ malignancy is associated with an increased incidence of acute ischemic stroke (AIS),” Aayushi Garg, MD, of the department of neurology at the University of Iowa Hospitals and Clinics, and colleagues wrote. “There is further evidence to support that patients with malignancy also have a higher risk of early complications, disability, recurrent thromboembolic events